Daniel Tanner, BSc, EMBA, DIC

Daniel Tanner has a diverse work experience in the life sciences industry. Daniel is currently working at Cerba Research as the Chief Commercial Officer (CCO) & General Manager. Prior to that, they worked at Bioclinica as the Vice President, eHealth - Enterprise Accounts from January 2017 to November 2018. From July 2013 to July 2016, they were a Senior Director, Business Development at PAREXEL. Before that, they served as the Director, Sales, Strategic Development at ICON plc from December 2009 to June 2013. Daniel also worked at Kendle International as a Business Development Executive from July 2006 to December 2009, and at inVentiv Health Clinical as a Clinical Research Associate (CRA) from September 2004 to July 2006.

Daniel Tanner holds a BSc in Biochemistry with 1st Class Honours from the University of Warwick, which they completed from 2001 to 2004. In 2009, they pursued an MBA in Executive Management from Imperial College Business School, concluding in 2010. Recently, in 2021, they participated in the HMX Pro online certificate program offered by Harvard Medical School. Additionally, Daniel obtained a certification in "B2B Go-to-Market Strategy: How to Transform Your Business" from LinkedIn in March 2023. Prior to their higher education, they attended Sir William Borlase's Grammar School from 1994 to 2000, although specific degrees or fields of study for this period are not provided.